Skip to main content
Press Release

Federal Jury Convicts Baton Rouge Doctor of Distribution of Controlled Substances by a Physician

For Immediate Release
U.S. Attorney's Office, Middle District of Louisiana

United States Attorney Ronald C. Gathe, Jr., announced the conviction of Dr. Randy J. Lamartiniere, age 64, of Baton Rouge, Louisiana.  Lamartiniere was indicted by a federal grand jury on October 27, 2021 and charged with distribution of controlled substances by a physician. 

After a five-day trial before District Judge Brian A. Jackson, on December 9, 2022, the jury unanimously convicted Lamartiniere of 20 counts of distribution of controlled substances.  As the evidence at trial demonstrated, from in or about March 2015 through January 2016, Lamartiniere, in exchange for cash, wrote medically unnecessary prescriptions for large quantities of Adderall, fentanyl, hydrocodone, methadone, oxycodone, and oxymorphone.  Lamartiniere’s fee typically ranged from $100 to $300 per visit, and he accepted no form of health insurance for “doctor visits.” At the end of these “visits,” Lamartiniere routinely issued prescriptions for Adderall and opioids, therefore, distributing and dispensing controlled substances that were not for a legitimate medical purpose and outside the usual course of a legitimate medical practice.

As a result of his convictions, Dr. Lamartiniere now faces a maximum sentence in federal prison of twenty years for each of the twenty counts of conviction, as well as significant fines, forfeiture, restitution, and supervised release.

This case was investigated by the Drug Enforcement Administration, with assistance from the East Baton Rouge, West Baton Rouge, and Iberville Parish Sheriff’s Offices, along with the Baton Rouge Police Department. The case was prosecuted by Assistant United States Attorneys Paul L. Pugliese, who also serves as Opioid Coordinator; Alan A. Stevens, who also serves as Senior Litigation Counsel; and Harley W. Ferguson.

Updated December 13, 2022

Prescription Drugs